<DOC>
	<DOCNO>NCT02865876</DOCNO>
	<brief_summary>The objective study evaluate efficacy safety accelerate cross-linking ( Avedro Inc. , Waltham , USA ) management microbial keratitis adjunctive therapy .</brief_summary>
	<brief_title>Effectiveness Corneal Accelerated Crosslinking Infectious Keratitis</brief_title>
	<detailed_description>Investigators perform comprehensive ophthalmological examination , include evaluation risk factor ( immunosuppressive status , ocular trauma , previous ocular surgery , contact lens wear , topical corticosteroid use ) , best-corrected visual acuity ( Snellen chart ) , slit-lamp biomicroscopy , tonometry fundoscopy . In addition , anterior segment optical coherence tomography imaging ( Visante , Carl Zeiss Meditec , Dublin , California , USA ) , corneal scrape , culture clinical photograph day 1 , day 7 , month 1 3 analyze . Each participant assign one four group randomization . Group 1 : Initial ulcer treatment antibiotic plus sham ( n = 66 ) , partcipants receive topical moxifloxacin 0,5 % ( Vigamoxi , Alcon , Texas , USA ) sham CXL ; Group 2 : Initial ulcer treatment antibiotic plus cross-linking ( CXL ) ( n = 66 ) receive moxifloxacin plus CXL ( riboflavin 0.1 % 10 minute irradiation 30 mW/cm2 3 minute use accelerated CXL ) ; Group 3 : Refractory corneal ulcer treatment antibiotic plus sham ( n=66 ) , receive topical antibiotic plus sham CXL ; Group 4 : Refractory corneal ulcer treatment antibiotic plus CXL receive standard medication plus CXL . Statistical analysis divide four phase : 1 ) Analysis compliance , 2 ) Intention treat , 3 ) Losses follow-up 4 ) Variable-response ( heal ) use Stata/MP 12.0 ( Stata Corp. , College Station , TX ) .</detailed_description>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Keratitis</mesh_term>
	<criteria>Subjects infectious keratitis ( initial refractory treatment ) include bacterial mycotic keratitis size large 3 mm herpetic keratitis Acanthamoeba keratitis pregnancy endophthalmitis systemic immunosuppression</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Infectious keratitis</keyword>
	<keyword>Cross-linking</keyword>
</DOC>